title: Fansidar resistance in the Philippines.
authors.affiliation: U.S. Naval Medical Research Unit No. 2, APO San Francisco, California 96528.
authors.forename: G
authors.initials: G
authors.lastname: Watt
authors.forename: L P
authors.initials: LP
authors.lastname: Padre
authors.forename: L R
authors.initials: LR
authors.lastname: Tuazon
authors.forename: L W
authors.initials: LW
authors.lastname: Laughlin
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002675:Child, Preschool; D004338:Drug Combinations / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy; D008297:Male; D010679:Philippines; D010963:Plasmodium falciparum / Q000187:drug effects; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine